HIV-DNA Vaccination Following Transfer of a Large Number of Activated T Cells Enhances Immunoresponses Against HIV-1

This publication has 21 references indexed in Scilit:

• Toward an Understanding of the Correlates of Protective Immunity to HIV Infection
  Science, 1996
• A Macromolecular Multicomponent Peptide Vaccine Prepared Using the Glutaraldehyde Conjugation Method with Strong Immunogenicity for HIV-1
  Clinical Immunology and Immunopathology, 1995
• Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp120
  Cellular Immunology, 1995
• A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients
  Biomedicine & Pharmacotherapy, 1993
• Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection
  Journal of Molecular Recognition, 1993
• An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself.
  The Journal of Experimental Medicine, 1990
• Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes
  Nature, 1988
• CD8 ⁺ Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
  Science, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982